Nalaganje...
Population pharmacokinetics of rituximab in patients with diffuse large B‐cell lymphoma and association with clinical outcome
AIMS: Pharmacokinetic (PK) studies suggest that there is a room for improvement in clinical use of rituximab through more individualized treatment. The objective of this study was to characterize rituximab PK in 29 newly diagnosed patients with diffuse large B‐cell lymphoma treated with rituximab in...
Shranjeno v:
| izdano v: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5510082/ https://ncbi.nlm.nih.gov/pubmed/28239897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13271 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|